Quantifying the impact of post-slaughter meat treatments on human disease risk from Campylobacter-contaminated broiler-based meals
Microbial Risk Analysis · 2026-10 · 100395
DOI: 10.1016/j.mran.2026.100395 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Risk Analysis, 2026-10. Verfasst von Alessandro Foddai und 4 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Green Development and Demonstration Programme.
Abstract (Originalsprache)
This study assessed the impact of two post-slaughter broiler - meat treatments, slurry-ice spraying and modified-atmosphere packaging (MAP-O₂; ∼80% O₂ and 20% CO₂), on the risk of human disease from eating a Campylobacter -contaminated broiler-based meal. Danish 2024 surveillance data on culture-tested leg skin (LS) samples, from the four main slaughterhouse companies, were incorporated into a quantitative microbial risk assessment (QMRA) model. Six scenarios were evaluated: a reference scenario without treatment and five treatment scenarios reflecting reductions in Campylobacter carcass concentration (in colony-forming units per gram, CFU/g) from two Danish studies. Campylobacter concentration reductions were applied uniformly across flocks. Scen-I simulated slurry-ice treatment (10.9% CFU/g reduction), Scen-II to IV evaluated MAP-O₂ treatment (84.5-94.2% reductions), and Scen-V assessed their combined sequential effect. Next, the average annual and monthly risk per serving were divided by estimates from chilled (non-treated) meat from baseline years 2019–2021, to assess the relative risk (RR) change in 2024. Descriptive analyses and Generalized Estimating Equation (GEE) models investigated effects of scenarios on apparent flock prevalence (AP) and concentrations, which drove risk estimates. Model assumptions were assessed through diagnostic checks, while sensitivity analyses evaluated alternative GEE correlation structures and an alternative slurry-ice scenario based on a higher CFU/g reduction factor (20.7%) than that used in Scen-I . Under the reference scenario, the average RR-2024 was 1.03, suggesting 3% increase in risk per serving, compared to baseline years. Slurry-ice ( Scen-I ) produced modest reductions in AP and concentrations, corresponding to a small (-7%) decrease in RR, while MAP-O₂ had a strong effect across seasons, slaughterhouses and flock types (conventional and organic). These effects translated into an overall 67–84% RR reduction. MAP-O₂ consistently reduced all monthly RRs below baseline levels. Combining slurry-ice with MAP-O₂ provided a marginal additional benefit compared with MAP-O₂ alone. Results were robust across statistical and sensitivity analyses. MAP-O₂ appeared the most effective post-slaughter risk mitigation measure, especially in higher-risk seasons and slaughterhouses. Results are relevant for slaughterhouse managers and policymakers when considering effectiveness of interventions aimed at reducing Campylobacter risks from broiler meat.
Förderung
- Green Development and Demonstration Programme
Zitieren
APA
Foddai, A., Calvo-Fernandez, C., Lassen, B., Nauta, M., & Takeuchi-Storm, N. (2026). Quantifying the impact of post-slaughter meat treatments on human disease risk from Campylobacter-contaminated broiler-based meals. Microbial Risk Analysis, 100395. https://doi.org/10.1016/j.mran.2026.100395
Vancouver
Foddai A, Calvo-Fernandez C, Lassen B, Nauta M, Takeuchi-Storm N. Quantifying the impact of post-slaughter meat treatments on human disease risk from Campylobacter-contaminated broiler-based meals. Microbial Risk Analysis. 2026:100395. doi:10.1016/j.mran.2026.100395
BibTeX
@article{Foddai2026,
author = {Foddai, Alessandro and Calvo-Fernandez, Cristina and Lassen, Brian and Nauta, Maarten and Takeuchi-Storm, Nao},
title = {Quantifying the impact of post-slaughter meat treatments on human disease risk from Campylobacter-contaminated broiler-based meals},
journal = {Microbial Risk Analysis},
year = {2026},
pages = {100395},
doi = {10.1016/j.mran.2026.100395}
}
EUVIMED